LakePharma is pleased to organize its annual Symposium to bring together individuals and organizations in the biotech community to discuss the latest developments in biologics.
The 2018 symposium will cover topics such as the latest advances in antibody development, as well as innovative technologies that are helping to bring about the next generation of protein therapeutics and products including cell therapies.
The conference is designed to benefit scientists currently working in the biopharmaceutical industry who want to improve their awareness of the latest advancements in protein engineering and antibody discovery, as well as non-scientists who seek a better understanding of the processes, challenges and opportunities in the industry.
Hua Tu, Ph.D. CEO, LakePharma, Inc.
Norman Garceau, Ph.D. VP, Technology, LakePharma, Inc.
Yuko Terasawa, Ph.D. SVP, Corporate Development, Nanomolar, Inc.
Steven Banerjee, Founder and CEO, Mekonos
Damien Bates, M.D., Ph.D., FRACS, MBA, Chief Medical Officer & Head of Research at SanBio
Prasun Mishra, Ph.D., Founder and CEO, Agility Pharmaceuticals
Janette Phi, COO, Xcell Biosciences
Deepak Srivastata, M.D., President, Gladstone Institutes
Hong Tan, Ph.D., CEO, Probe Life
Yuko Terasawa, Ph.D., SVP, Corporate Development, Nanomolar
Hua Tu, Ph.D., CEO, LakePharma
Jordon Wang, Ph.D., VP, Antibody Discovery, LakePharma
Andre Watson, Founder and CEO, Ligandal
Friday: October 5, 2018
8:30 am - 6 pm
Schedule to be announced.
Interested exhibitors for 2018, please contact email@example.com for information.